CrystalVision Develops Customized Application for Asentral, Inc. IRB

Salisbury, Massachusetts – CrystalVision has recently developed and launched a new web site for Asentral, Inc. Institutional Review Board (IRB). The web site ( contains information relating to working with Asentral, Inc. IRB during clinical trials. Their clientele include pharmaceutical, biotech and medical device companies. CrystalVision will also provide ongoing site optimization to enhance their search engine ranking.

In addition to a new web site, CrystalVision also developed a customized web application for Asentral IRB called “The Sentry.” The web application streamlines the sharing of documents between Asentral and their clients including Sponsors, Contract Research Organizations and clinical research sites. The web application provides for secure file transfers, automated notifications and data storage for Asentral, Inc. IRB’s clients. The application was custom developed based on Asentral, Inc. IRB’s requirements. It employs the use of administrative and technical controls, and is based upon the elements of compliance with electronic record keeping as outlined in the Code of Federal Regulations Chapter 21, Part 11.

About Asentral, Inc. IRB:

Asentral, Inc. IRB is an independent, central institutional review board, incorporated in 2001. Asentral, Inc. IRB reviews and oversees clinical research trials per the Federal Regulations with the safety, welfare and dignity of human research subjects in mind. Asentral, Inc. has been selected by the National Cancer Institute as a partner in the Cancer Trials Support Unit (CTSU) program. They have been audited by the FDA (through a “not-for-cause” audit) and found to have no non-compliances. The Board at Asentral, Inc. is drawn from the world-class medical and educational communities of Greater Boston to seat a review board with unparalleled expertise across a wide range of public health issues, concerns and initiatives.

This entry was posted in Press Releases. Bookmark the permalink.